4'-Hydroxytamoxifen | CAS 82413-23-8 - Request Quote
4'-Hydroxytamoxifen
| SZ CAT No: | SZ-T038010 |
| CAS No | 82413-23-8 |
| Mol.F. | C26H29NO2 |
| Mol.Wt. | 387.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
4'-Hydroxytamoxifen is chemically (Z)-4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-1-phenylbut-1-en-2-yl)phenol. 4'-Hydroxytamoxifen is supplied with detailed characterization data compliant with regulatory guideline. 4'-Hydroxytamoxifen can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tamoxifen.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 82413-23-8
Purchase 82413-23-8
Order 82413-23-8
Enquire 82413-23-8
price of 82413-23-8
82413-23-8 Supplier
82413-23-8 Manufacturer
82413-23-8 Exporter
buy high quality 4'-Hydroxytamoxifen
Purchase 4'-Hydroxytamoxifen
4'-Hydroxytamoxifen suppliers
4'-Hydroxytamoxifen manufacturers
4'-Hydroxytamoxifen price
Order 4'-Hydroxytamoxifen
Enquire 4'-Hydroxytamoxifen
4'-Hydroxytamoxifen cost
4'-Hydroxytamoxifen Supplier
4'-Hydroxytamoxifen Distributor
4'-Hydroxytamoxifen for Method Validation
Tamoxifen Reference Standard
4'-Hydroxytamoxifen for ANDA Filing
4'-Hydroxytamoxifen for Forced Degradation Studies
4'-Hydroxytamoxifen Identification Standards
4'-Hydroxytamoxifen for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.